Reaction
Serum Ferritin Decreased reporting signals
As of the last recalculation, Serum Ferritin Decreased appears in 1,693 FAERS reports alongside 24 co-occurring drug terms. The strongest observed disproportionality signal is DEFERASIROX (PRR 46.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Deferasirox | 94 | 46.1 | 46.2 |
| Iron Sucrose | 29 | 38.0 | 38.1 |
| Infliximab-Dyyb | 62 | 27.0 | 27.1 |
| Anakinra | 28 | 21.1 | 21.1 |
| Mesalamine | 66 | 15.0 | 15.0 |
| Iron | 75 | 14.4 | 14.4 |
| Ado-Trastuzumab Emtansine | 9 | 13.2 | 13.2 |
| Vedolizumab | 84 | 12.6 | 12.6 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 7 | 10.1 | 10.1 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 8 | 8.9 | 9.0 |
| Hydroxyzine Hydrochloride | 9 | 8.5 | 8.5 |
| Hydroxyzine Hydrochloride Oral | 9 | 8.5 | 8.5 |
| Infliximab | 139 | 8.4 | 8.4 |
| Golimumab | 53 | 7.8 | 7.8 |
| Hydroxyurea | 13 | 7.6 | 7.6 |
| Meropenem | 18 | 7.0 | 7.0 |
| Omalizumab | 42 | 6.2 | 6.2 |
| Inclisiran | 3 | 4.6 | 4.6 |
| Abatacept | 50 | 4.5 | 4.5 |
| Ruxolitinib | 26 | 4.5 | 4.5 |
| Clozapine | 40 | 4.0 | 4.0 |
| Eltrombopag Olamine | 7 | 3.7 | 3.7 |
| Medroxyprogesterone Acetate | 15 | 3.7 | 3.7 |
| Romosozumab-Aqqg | 4 | 3.6 | 3.6 |